Avricore Health (TSX-V:AVCR, OTC:AVCRF) CEO Hector Bremner joined Steve Darling from Proactive to share news the company has provide an update on 2022 and what goals have been set for 2023. Bremner telling Proactive more about its key offering HealthTab and the scaling it saw in 2022. Bremner also shared his vision for 2023 and the goals the company looks to achieve including further expansion of HealthTab with current partners, International expansion, and revenue growth and profitability.
Avricore Health looks to continue positive growth in 2023 after success in 2022
